BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37631291)

  • 1. Physical Characterization to Improve Scalability and Potential of Anesthetic-Loaded Nanodroplets.
    Ting SG; Lea-Banks H; Hynynen K
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-sensitive nanodroplets achieve targeted neuromodulation.
    Lea-Banks H; Meng Y; Wu SK; Belhadjhamida R; Hamani C; Hynynen K
    J Control Release; 2021 Apr; 332():30-39. PubMed ID: 33600879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point.
    Vezeridis AM; de Gracia Lux C; Barnhill SA; Kim S; Wu Z; Jin S; Lux J; Gianneschi NC; Mattrey RF
    J Control Release; 2019 May; 302():54-62. PubMed ID: 30928487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized anesthesia of a specific brain region using ultrasound-responsive barbiturate nanodroplets.
    Lea-Banks H; O'Reilly MA; Hamani C; Hynynen K
    Theranostics; 2020; 10(6):2849-2858. PubMed ID: 32194839
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted drug delivery with focused ultrasound-induced blood-brain barrier opening using acoustically-activated nanodroplets.
    Chen CC; Sheeran PS; Wu SY; Olumolade OO; Dayton PA; Konofagou EE
    J Control Release; 2013 Dec; 172(3):795-804. PubMed ID: 24096019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailoring the size of ultrasound responsive lipid-shelled nanodroplets by varying production parameters and environmental conditions.
    Ferri S; Wu Q; De Grazia A; Polydorou A; May JP; Stride E; Evans ND; Carugo D
    Ultrason Sonochem; 2021 May; 73():105482. PubMed ID: 33588208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time and Frequency Characteristics of Cavitation Activity Enhanced by Flowing Phase-Shift Nanodroplets and Lipid-Shelled Microbubbles During Focused Ultrasound Exposures.
    Zhang S; Xu T; Cui Z; Shi W; Wu S; Zong Y; Niu G; He X; Wan M
    Ultrasound Med Biol; 2019 Aug; 45(8):2118-2132. PubMed ID: 31151732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-millimetre precision of drug delivery in the brain from ultrasound-triggered nanodroplets.
    Lea-Banks H; Hynynen K
    J Control Release; 2021 Oct; 338():731-741. PubMed ID: 34530050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse effects of flowing phase-shift nanodroplets and lipid-shelled microbubbles on subsequent cavitation during focused ultrasound exposures.
    Zhang S; Cui Z; Xu T; Liu P; Li D; Shang S; Xu R; Zong Y; Niu G; Wang S; He X; Wan M
    Ultrason Sonochem; 2017 Jan; 34():400-409. PubMed ID: 27773262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent anti-vascular therapy and chemotherapy in solid tumors using drug-loaded acoustic nanodroplet vaporization.
    Ho YJ; Yeh CK
    Acta Biomater; 2017 Feb; 49():472-485. PubMed ID: 27836803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Release from Phase-Changeable Nanodroplets Triggered by Low-Intensity Focused Ultrasound.
    Cao Y; Chen Y; Yu T; Guo Y; Liu F; Yao Y; Li P; Wang D; Wang Z; Chen Y; Ran H
    Theranostics; 2018; 8(5):1327-1339. PubMed ID: 29507623
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional ultrasound-triggered phase-shift perfluorocarbon nanodroplets for cancer therapy.
    Guo R; Xu N; Liu Y; Ling G; Yu J; Zhang P
    Ultrasound Med Biol; 2021 Aug; 47(8):2064-2079. PubMed ID: 33992473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the Acoustic Vaporization Threshold of Lipid-Coated Perfluorobutane Nanodroplets Using Both High-Speed Optical Imaging and Acoustic Methods.
    Wu Q; Mannaris C; May JP; Bau L; Polydorou A; Ferri S; Carugo D; Evans ND; Stride E
    Ultrasound Med Biol; 2021 Jul; 47(7):1826-1843. PubMed ID: 33820668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cavitation characteristics of flowing low and high boiling-point perfluorocarbon phase-shift nanodroplets during focused ultrasound exposures.
    Xu T; Cui Z; Li D; Cao F; Xu J; Zong Y; Wang S; Bouakaz A; Wan M; Zhang S
    Ultrason Sonochem; 2020 Jul; 65():105060. PubMed ID: 32199255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Acoustic Droplet Vaporization through the Active Magnetic Accumulation of Drug-Loaded Magnetic Particle-Encapsulated Nanodroplets (MPE-NDs) in Cancer Therapy.
    Huang S; Guo W; An J; Zhang J; Dong F; Wang D; Feng F; Zhang J
    Nano Lett; 2022 Oct; 22(20):8143-8151. PubMed ID: 36194752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ultrasound-responsive chitosan/perfluorohexane nanodroplets for image-guided smart delivery of an anticancer agent: Curcumin.
    Baghbani F; Chegeni M; Moztarzadeh F; Hadian-Ghazvini S; Raz M
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():186-193. PubMed ID: 28254284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery.
    Wu SY; Fix SM; Arena CB; Chen CC; Zheng W; Olumolade OO; Papadopoulou V; Novell A; Dayton PA; Konofagou EE
    Phys Med Biol; 2018 Jan; 63(3):035002. PubMed ID: 29260735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel method for the formation of monodisperse superheated perfluorocarbon nanodroplets as activatable ultrasound contrast agents.
    de Gracia Lux C; Vezeridis AM; Lux J; Armstrong AM; Sirsi SR; Hoyt K; Mattrey RF
    RSC Adv; 2017; 7(77):48561-48568. PubMed ID: 29430294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
    Baghbani F; Moztarzadeh F
    Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic preparation of various perfluorocarbon nanodroplets: Characterization and determination of acoustic droplet vaporization (ADV) threshold.
    Melich R; Bussat P; Morici L; Vivien A; Gaud E; Bettinger T; Cherkaoui S
    Int J Pharm; 2020 Sep; 587():119651. PubMed ID: 32707242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.